- Home
- RXRX vs CRGY Comparison
RXRX vs CRGY Comparison
Compare RXRX & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CRGY
- Stock Information
- Founded
- RXRX 2013
- CRGY 1986
- Country
- RXRX United States
- CRGY United States
- Employees
- RXRX N/A
- CRGY N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CRGY Oil & Gas Production
- Sector
- RXRX Health Care
- CRGY Energy
- Exchange
- RXRX Nasdaq
- CRGY Nasdaq
- Market Cap
- RXRX 2.0B
- CRGY 2.5B
- IPO Year
- RXRX 2021
- CRGY N/A
- Fundamental
- Price
- RXRX $5.13
- CRGY $8.88
- Analyst Decision
- RXRX Buy
- CRGY Buy
- Analyst Count
- RXRX 5
- CRGY 12
- Target Price
- RXRX $7.00
- CRGY $16.40
- AVG Volume (30 Days)
- RXRX 33.0M
- CRGY 3.5M
- Earning Date
- RXRX 08-07-2025
- CRGY 08-04-2025
- Dividend Yield
- RXRX N/A
- CRGY 5.42%
- EPS Growth
- RXRX N/A
- CRGY N/A
- EPS
- RXRX N/A
- CRGY N/A
- Revenue
- RXRX $59,790,000.00
- CRGY $3,223,618,000.00
- Revenue This Year
- RXRX $23.51
- CRGY $25.73
- Revenue Next Year
- RXRX $53.87
- CRGY N/A
- P/E Ratio
- RXRX N/A
- CRGY N/A
- Revenue Growth
- RXRX 29.32
- CRGY 31.58
- 52 Week Low
- RXRX $3.79
- CRGY $6.83
- 52 Week High
- RXRX $12.36
- CRGY $16.94
- Technical
- Relative Strength Index (RSI)
- RXRX 52.66
- CRGY 47.66
- Support Level
- RXRX $4.96
- CRGY $8.48
- Resistance Level
- RXRX $5.48
- CRGY $9.13
- Average True Range (ATR)
- RXRX 0.38
- CRGY 0.37
- MACD
- RXRX 0.01
- CRGY -0.07
- Stochastic Oscillator
- RXRX 38.32
- CRGY 26.56
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.